Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2003
03/13/2003US20030050262 Inhibition of neurodegeneration
03/13/2003US20030050260 Method for treating diabetes by reducing in vivo cathepsin L activity
03/13/2003US20030050259 Method and reagent for the treatment of cardiac disease
03/13/2003US20030050251 A polypeptide which inhibits or reduces tumor progression and/or metastasis
03/13/2003US20030050249 Complexes of alpha-6 integrin subunits with small peptides and methods for treating indications resulting from modulation of integrin-mediated responses by altering signal transduction
03/13/2003US20030050248 Novel amino acid and peptide inhibitors of Staphylococcus virulence
03/13/2003US20030050247 Peptides which are modified with at least one hydrocarbyl group and which possess antimicrobial acitivity
03/13/2003US20030050246 Peptides having antiangiogenic activity
03/13/2003US20030050245 A protein molecule that is a cofactor of tissue plasminogen activator and has a residue of lysine and/or arginine or an equivalent; angiogenesis inhibitors; antiinflammatory agents; antitumor agents; aging; degrads amyloid
03/13/2003US20030050244 Controlling the action of cytokines, particularly chemokines, by inhibiting their binding with receptors; used as immunogens for use as metazoan parasite vaccines; antiallergens; veterinary medicine
03/13/2003US20030050243 Administering an effective, nontoxic amount of a peptide replacement agent for the N-methyl-C-aspartate receptor or neural protein interaction domain to prevent the triggering of excitotoxicity and brain damage; antiischemic agents
03/13/2003US20030050242 Protein polymerization inhibitors and methods of use
03/13/2003US20030050241 Extracellular proteins, secreted proteins, membrane-bound proteins; nucleic acid molecules encoding these polypeptides, as well as vectors and host cells having those nucleic acid sequences; fusion to heterologous polypeptides; antibodies
03/13/2003US20030050240 Extracellular proteins, secreted proteins, membrane-bound proteins; nucleic acid molecules encoding these polypeptides, as well as vectors and host cells having those nucleic acid sequences; fusion to heterologous polypeptides; antibodies
03/13/2003US20030050239 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030050238 Stable composition comprising epidermal growth factor as an active ingredient
03/13/2003US20030050237 Treatment of noninsulin dependent diabetes mellitus in a mammal by administering a sustained-release form of a glucagon-like protein (GLP-1 (7-37) having insulintropic activity; drug delivery
03/13/2003US20030050236 Compounds that enhance tumor death
03/13/2003US20030050234 Conotoxin peptide extracted from the venom of a marine snail, Conus magnus (cono=cone); disorders associated with voltage gated sodium ion channel; neuromuscular blocking agents; local anesthetics; neuroprotective agents; analgesics
03/13/2003US20030050233 Peptide combination for the treatment of cancer
03/13/2003US20030050231 Discovery of new human colon-associated polynucleotides, the polypeptides encoded by them, and antibodies that immuno-specifically bind these polypeptides; diagnosis/medical; anticarcinogenic, -metastasis agents; other colon diorders
03/13/2003US20030050230 A nucleic acid encoding a family (title) of kinases from a group of sixteen polypeptides; identifying a substance that modulates kinase activity; autoimmune diseases; organ transplantation, cardiovascular disease, stroke, renal failure
03/13/2003US20030050228 Administering by mouth an effective amount of an insulin polypeptide derivative within one hour of ingestion of a meal by the patient to provide an insulin drug concentration in portal vein blood of 10-1,000 U/ml within 60 minutes
03/13/2003US20030050227 Pharmaceutical composition, reagent and method for intracerebral delivery of pharmaceutically active ingredient or labeling substance
03/13/2003US20030050226 Dopamine analog amide
03/13/2003US20030050225 Compositions and methods to control bleeding
03/13/2003US20030050223 Crystal forms and mutants of RANK ligand
03/13/2003US20030049865 Microfabricated devices for the storage and selective exposure of chemicals and devices
03/13/2003US20030049838 Generation of neuronal cell for use in the treatment of nervous system disorders; prepare nutrient broth contain nerve growth factor, inoculate with cells, propagate and monitor cells
03/13/2003US20030049837 In vitro proliferation of pluripotent neural stem cell; obtain mammalian neural tissues, dissociate neural tissue into suspension, culture, passaging neural stem cell progeny to a second culture and propagate cells
03/13/2003US20030049828 Oncogenic protein for use in the diagnosis and treatment of tumors
03/13/2003US20030049826 Bone morphogenic protein for use in the treatment of bone disorders; for use as wound healing agent
03/13/2003US20030049823 eNOS mutations useful for gene therapy and therapeutic screening
03/13/2003US20030049817 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment, and prevention of tumors and cell proliferation disorders
03/13/2003US20030049816 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment, and prevention of tumors and cell proliferation disorders
03/13/2003US20030049815 Recombinant bacterial phytases and uses thereof
03/13/2003US20030049798 Fusion protein for use in the treatment and prevention of autoimmune and cancer diseases
03/13/2003US20030049797 Hybrid proteins for autoimmune disease
03/13/2003US20030049795 Peptide for use in the treatment and prevention of inflammation, cancer, arteriosclerosis and psoriasis
03/13/2003US20030049794 DNA encoding a human dopamine D1 receptor and uses thereof
03/13/2003US20030049793 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins and uses thereof
03/13/2003US20030049792 Peptide for use in the diagnosis, treatment and prevention of inflammation, cancer, arteriosclerosis and psoriasis
03/13/2003US20030049791 Goodpasture antigen binding protein
03/13/2003US20030049790 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
03/13/2003US20030049788 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation disorders
03/13/2003US20030049787 Polynucleotide coding protein for use in the diagnosis and prevention of infections, heart defects, hypotension, ulcers, hypertension, urogenital, osteoporosis, angina pectoris, asthma, allergies, pain, cancer and nervous system disorders
03/13/2003US20030049784 Tissue factor for use in the treatment of clotting, thrombotic, cardiovascular and cancer disorders
03/13/2003US20030049735 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049734 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049733 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative, tumor, nervous system, arthritis, graft-versus-host disease, stroke, psoriasis and inflammatory bowel disease
03/13/2003US20030049732 Apoptosis related polynucleotides, polypeptides, and antibodies
03/13/2003US20030049730 ABCG5 and ABCG8: compositions and methods of use
03/13/2003US20030049728 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
03/13/2003US20030049725 Anti-TNF antibodies, compositions, methods and uses
03/13/2003US20030049723 MAGE-A3 peptides presented by HLA class II molecules
03/13/2003US20030049713 Evaluating modulator of kallikrein generation; obtain prekallikrein mixture, incubate with kininogen, phosphate and zinc ions and modulator, monitor adjustment in generation of kallikrein
03/13/2003US20030049706 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment and prevention of bacterial infections
03/13/2003US20030049703 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer disorders
03/13/2003US20030049699 Polypeptide for use in the treatment of cell proliferation disorders
03/13/2003US20030049697 Detection of potassium channel modulators for treatment of heart, vascular and endrocrine pathologies; obtain sample, incubate with modulator, monitor effect of modulator on transport protein activity
03/13/2003US20030049696 Isolation of human regulatory lymphocytes; obtain cell sample, incubate with cd antigen binding agents, recover cells positive for cd antigen binding agent
03/13/2003US20030049691 Nucleotide sequences coding polypeptide for use as diagnostic tool in the detection of allergic response to mammalian animal dander
03/13/2003US20030049689 Generation of polypeptide for use in the treatment of injuries, infections and cancer; obtain library of peptides, join to generate polypeptide, evaluate activity of polypeptide
03/13/2003US20030049685 Synthetic antigens for the detection of antibodies to hepatitis C virus
03/13/2003US20030049684 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
03/13/2003US20030049682 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
03/13/2003US20030049681 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049677 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049676 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
03/13/2003US20030049672 Modulation of protein binding; obtain sample containing polypeptides, incubate with modulator, detect adjustment in protein activity
03/13/2003US20030049669 Protein for use in detection of bacterial infections
03/13/2003US20030049664 87144, human amino acid transporter family member and uses therefor
03/13/2003US20030049662 Oligonucleotides for use in the treatment of wounds, cardiovascular, cell proliferative and developmental disorders
03/13/2003US20030049648 37 staphylococcus aureus genes and polypeptides
03/13/2003US20030049643 G protein-coupled receptors for use in the treatment of cardiovascular, nervous system, angina pectoris, inflamatory bowel, allergies and gastrointestinal disorders
03/13/2003US20030049641 Detection of immunosuppressive agent; obtain tissue, incubate with modulator, monitor sample for nuclear translocation, nuclear translocation indicates presence of modulator
03/13/2003US20030049640 Proteins, genes and their use for diagnosis and treatment of vascular response
03/13/2003US20030049638 Nucleotide sequences coding polypeptide for use in the treatment and prevention of cell proliferative, nervous system and tumor disorders
03/13/2003US20030049633 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049622 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049621 Secreted and transmembrane polypeptides and nucleic acids enconding the same
03/13/2003US20030049618 186 human secreted proteins
03/13/2003US20030049617 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
03/13/2003US20030049611 Pentamer peptide amide, algpgnh2, which inhibits viral infectivity and methods of use thereof
03/13/2003US20030049609 Viral proteins capable of binding LAR
03/13/2003US20030049606 Novel anti-viral and anti-proliferative agents derived from STAT1 transcription factor
03/13/2003US20030049604 Viral proteins for use in the treatment and prevention of infection and viral diseases
03/13/2003US20030049603 Designing preferential chemokines; obtain phage display library, incubate with cells, harvest cells, release phage, incubate with bacteria and clone phage, recover clones
03/13/2003US20030049336 Composition and method for topical treatment of androgenic alopecia
03/13/2003US20030049280 Spontaneous emulsions containing cyclosporine
03/13/2003US20030049277 Composition for treatment of and method of monitoring hepatitis C virus using interferon-TAU
03/13/2003US20030049273 Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
03/13/2003US20030049271 Diagnosis, therapy of bacteria infections
03/13/2003US20030049264 Releasing neurotransmitters; analgesics
03/13/2003US20030049261 Administering chitinase inhibitor
03/13/2003US20030049259 Control of lymphocyte localization by LEEP-CAM activity
03/13/2003US20030049258 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
03/13/2003US20030049256 Cytokine antagonists for neurological and neuropsychiatric disorders
03/13/2003US20030049255 Interleukin-1 receptors in the treatment of diseases
03/13/2003US20030049250 Anticholesterol agents, cardiovascular disorders; administering neuropeptide y
1 ... 1888 1889 1890 1891 1892 1893 1894 1895 1896 1897 1898 1899 1900 1901 1902 1903 1904 1905 1906 1907 1908 ... 3163